Industry

October 2024 review: M&A, licensing, and investments in one place

October 2024 saw notable activity in mergers, acquisitions, and strategic investments within the biotech and life sciences industries.

Codex Committee on Nutrition and Foods for Special Dietary Uses Concludes 44th Session without Adopting Probiotic Guidelines

In the session's conclusion, CCNFSDU agreed to maintain the status quo for the next three to five years rather than start to work on new guidelines.

The gut, conductor of our health. The International Yakult Symposium congress report  

A symphony of microbiome insights: from early infancy to advanced age, the microbiome orchestrates critical processes that affect our health.

Health Canada Authorizes Functional Claim for SynbÆctive® Femme, a Patented Probiotic Formula for Women’s Health

The recently patented probiotic combination specifically focused on women’s urogenital health.

European microbiome leaders unite to accelerate global therapeutic development

The partnership aims to accelerate the development and approval of microbiome-based therapeutics by harmonizing regulatory frameworks.

Gender representation in microbiome conferences: a promising trend

An analysis conducted by MicrobiomePost reveals an encouraging trend toward gender parity among speakers at major microbiome-focused conferences globally.

Harnessing microbiome-based biomarkers: a multidisciplinary Delphi Consensus and EU’s new initiative

Delphi survey highlights promises and challenges in clinical use of microbiome-based biomarkers.

New partnership aims to revolutionize rheumatoid arthritis treatment through metabolomics

Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study announce partnership to better understand the molecular mechanisms of rheumatoid arthritis.

NIH grant fuels groundbreaking research on polyphenols, Alzheimer’s prevention, and the brain-gut-microbiome connection

Arpana Church (UCLA): ‘We’re hoping to better understand the role of dietary polyphenols in slowing the development of cognitive decline and how this is all influenced by the gut microbiome’.

Exploring gut microbiota in Autism Spectrum Disorder: a metagenomic case study comparing an ASD patient with an at-risk infant sibling

Microbiomepost conducted an exclusive interview with Martina Piacente, from Ebris - European Biomedical Research Institute of Salerno, about the role of gut microbiome in Autism Spectrum Disorder.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top